The site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 9:00 pm through Friday, September 11, 9:00 pm (BRT), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
Flow cytometric analysis of human TGF-β1 expressed by TGF-β1-transfected P3UI cells. Left Panel: Untransfected mouse P3UI myeloma cells (shaded histogram) and human TGF-β1-transfected P3UI cells (open histogram) were surface stained with PE Mouse anti-Human TGF-β1 antibody (Cat. No. 562339) using BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656). Right Panel: Untransfected (shaded histogram) and Human TGF- β1 transfected (open histogram) P3UI cells were fixed and permeabilized for 30 minutes with BD Cytofix/Cytoperm™ Fixation and Permeabilization Solution (Cat. No. 554722), washed with BD Perm/Wash™ Perm/Wash Buffer (Cat. No. 554723), and then stained with PE Mouse Anti-Human TGF- β1 (Cat. No. 562339). Flow cytometric fluorescence histograms were derived from gated events with the forward- and side light-scattering characteristics of intact cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of human TGF-β1 expressed by TGF-β1-transfected P3UI cells. Left Panel: Untransfected mouse P3UI myeloma cells (shaded histogram) and human TGF-β1-transfected P3UI cells (open histogram) were surface stained with PE Mouse anti-Human TGF-β1 antibody (Cat. No. 562339) using BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656). Right Panel: Untransfected (shaded histogram) and Human TGF- β1 transfected (open histogram) P3UI cells were fixed and permeabilized for 30 minutes with BD Cytofix/Cytoperm™ Fixation and Permeabilization Solution (Cat. No. 554722), washed with BD Perm/Wash™ Perm/Wash Buffer (Cat. No. 554723), and then stained with PE Mouse Anti-Human TGF- β1 (Cat. No. 562339). Flow cytometric fluorescence histograms were derived from gated events with the forward- and side light-scattering characteristics of intact cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of human TGF-β1 expressed by TGF-β1-transfected P3UI cells. Left Panel: Untransfected mouse P3UI myeloma cells (shaded histogram) and human TGF-β1-transfected P3UI cells (open histogram) were surface stained with PE Mouse anti-Human TGF-β1 antibody (Cat. No. 562339) using BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656). Right Panel: Untransfected (shaded histogram) and Human TGF- β1 transfected (open histogram) P3UI cells were fixed and permeabilized for 30 minutes with BD Cytofix/Cytoperm™ Fixation and Permeabilization Solution (Cat. No. 554722), washed with BD Perm/Wash™ Perm/Wash Buffer (Cat. No. 554723), and then stained with PE Mouse Anti-Human TGF- β1 (Cat. No. 562339). Flow cytometric fluorescence histograms were derived from gated events with the forward- and side light-scattering characteristics of intact cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of human TGF-β1 expressed by TGF-β1-transfected P3UI cells. Left Panel: Untransfected mouse P3UI myeloma cells (shaded histogram) and human TGF-β1-transfected P3UI cells (open histogram) were surface stained with PE Mouse anti-Human TGF-β1 antibody (Cat. No. 562339) using BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656). Right Panel: Untransfected (shaded histogram) and Human TGF- β1 transfected (open histogram) P3UI cells were fixed and permeabilized for 30 minutes with BD Cytofix/Cytoperm™ Fixation and Permeabilization Solution (Cat. No. 554722), washed with BD Perm/Wash™ Perm/Wash Buffer (Cat. No. 554723), and then stained with PE Mouse Anti-Human TGF- β1 (Cat. No. 562339). Flow cytometric fluorescence histograms were derived from gated events with the forward- and side light-scattering characteristics of intact cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of human TGF-β1 expressed by TGF-β1-transfected P3UI cells. Left Panel: Untransfected mouse P3UI myeloma cells (shaded histogram) and human TGF-β1-transfected P3UI cells (open histogram) were surface stained with PE Mouse anti-Human TGF-β1 antibody (Cat. No. 562339) using BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656). Right Panel: Untransfected (shaded histogram) and Human TGF- β1 transfected (open histogram) P3UI cells were fixed and permeabilized for 30 minutes with BD Cytofix/Cytoperm™ Fixation and Permeabilization Solution (Cat. No. 554722), washed with BD Perm/Wash™ Perm/Wash Buffer (Cat. No. 554723), and then stained with PE Mouse Anti-Human TGF- β1 (Cat. No. 562339). Flow cytometric fluorescence histograms were derived from gated events with the forward- and side light-scattering characteristics of intact cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of human TGF-β1 expressed by TGF-β1-transfected P3UI cells. Left Panel: Untransfected mouse P3UI myeloma cells (shaded histogram) and human TGF-β1-transfected P3UI cells (open histogram) were surface stained with PE Mouse anti-Human TGF-β1 antibody (Cat. No. 562339) using BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656). Right Panel: Untransfected (shaded histogram) and Human TGF- β1 transfected (open histogram) P3UI cells were fixed and permeabilized for 30 minutes with BD Cytofix/Cytoperm™ Fixation and Permeabilization Solution (Cat. No. 554722), washed with BD Perm/Wash™ Perm/Wash Buffer (Cat. No. 554723), and then stained with PE Mouse Anti-Human TGF- β1 (Cat. No. 562339). Flow cytometric fluorescence histograms were derived from gated events with the forward- and side light-scattering characteristics of intact cells. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The TW4-9E7 monoclonal antibody specifically binds to Human Transforming Growth Factor beta-1 (TGF-β1). TGF-β1 is a potent multifunctional cytokine that positively or negatively regulates numerous processes including development, hematopoiesis, tissue remodeling, wound repair, innate and adaptive immunity as well as cancer and autoimmune diseases. TGF-β1 is formed by the enzymatic cleavage of the TGF-β1 propeptide that is encoded by the TGFB1 gene and comprised of the Latency Associated Peptide (LAP) and TGF-β1. Prior to secretion, the dimeric LAP-TGF-β1 propeptide is cleaved resulting in a biologically inactive form of dimeric TGF-β1 that is noncovalently associated with dimeric LAP (latent TGF-β1). This complex may be expressed on the surface of TGF-β1-producing cells or be further processed by proteolytic removal of LAP to release the biologically active mature form of the soluble TGF-β1 homodimer. Many different cell types synthesize TGF-β1 and express specific receptors for it. The TW4-9E7 antibody recognizes both the intracellular latent bound form of TGF-β1 along with the membrane bound form of TGF-β1.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.